Tech Company Financing Transactions
Biosynthetic Technologies Funding Round
HG Ventures and private investors participated in a Series A funding round for Biosynthetic Technologies. The round was announced on 5/9/2019.
Transaction Overview
Company Name
Announced On
5/9/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
HG Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to grow their sales and marketing efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6320 Intech Blvd.
Indianapolis, IN 46278
USA
Indianapolis, IN 46278
USA
Phone
Website
Email Address
Overview
Biosynthetic Technologies (BT) manufactures a revolutionary new class of biobased synthetic molecules that are made from organic fatty acids found in plant oils. These highly-functional biosynthetic oils have numerous uses in the lubricant, chemical, and cosmetics industries, often outperforming their petroleum counterparts in similar applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Miller
Browse more venture capital transactions:
Prev: 5/8/2019: Nutrition Innovation venture capital transaction
Next: 5/9/2019: Sumo Logic venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs